This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 May;11(2):165-74.

doi: 10.1055/s-2008-1040433.

Prevention and therapy of viral hepatitis

W N Katkov¹, J L Dienstag

Affiliations

PMID: 1716004
DOI: 10.1055/s-2008-1040433

Review

Prevention and therapy of viral hepatitis

W N Katkov et al. Semin Liver Dis. 1991 May.

. 1991 May;11(2):165-74.

doi: 10.1055/s-2008-1040433.

Authors

W N Katkov¹, J L Dienstag

Affiliation

¹ Gastrointestinal Unit (Medical Services), Massachusetts General Hospital, Boston 02114.

PMID: 1716004
DOI: 10.1055/s-2008-1040433

No abstract available

PubMed Disclaimer

Similar articles

[The therapy of viral hepatitis in HIV-infected patients].
Rockstroh JK, Spengler U, Sauerbruch T. Rockstroh JK, et al. Dtsch Med Wochenschr. 1995 Dec 8;120(49):1705-8. doi: 10.1055/s-2007-1024392. Dtsch Med Wochenschr. 1995. PMID: 7497896 Review. German. No abstract available.
Viral hepatitis guide for practicing physicians. Cleveland Clinic of Medicine.
Younossi ZM. Younossi ZM. Cleve Clin J Med. 2000;67 Suppl 1:SI6-45. Cleve Clin J Med. 2000. PMID: 11068358 No abstract available.
Managing viral hepatitis.
Tang KH, Williams R. Tang KH, et al. Practitioner. 2003 Jun;247(1647):537-42. Practitioner. 2003. PMID: 12822322 Review. No abstract available.
Biotechnologies and liver diseases.
Sherlock S. Sherlock S. Forum (Genova). 1999 Jul-Dec;9(3 Suppl 3):63-6. Forum (Genova). 1999. PMID: 10607849
Viral hepatitis: epidemiology, treatment, prevention.
Bane A. Bane A. Ethiop Med J. 2008 Apr;46(2):193-200. Ethiop Med J. 2008. PMID: 21309211 Review. No abstract available.

See all similar articles

Cited by

Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.
Desombere I, Gijbels Y, Verwulgen A, Leroux-Roels G. Desombere I, et al. Clin Exp Immunol. 2000 Dec;122(3):390-9. doi: 10.1046/j.1365-2249.2000.01383.x. Clin Exp Immunol. 2000. PMID: 11122245 Free PMC article.
T cell responses to hepatitis B surface antigen are detectable in non-vaccinated individuals.
Weihrauch MR, von Bergwelt-Baildon M, Kandic M, Weskott M, Klamp W, Rosler J, Schultze JL. Weihrauch MR, et al. World J Gastroenterol. 2008 Apr 28;14(16):2529-33. doi: 10.3748/wjg.14.2529. World J Gastroenterol. 2008. PMID: 18442200 Free PMC article.
Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection.
Wölfel T, Schirmacher P, Schlaak J, Knolle P, Dienes HP, Dippold W, Meyer zum Büschenfelde KH, Gerken G. Wölfel T, et al. Clin Investig. 1994 Dec;72(12):1030-6. doi: 10.1007/BF00577750. Clin Investig. 1994. PMID: 7711410
Interferon in the management of chronic hepatitis B.
Perrillo RP. Perrillo RP. Dig Dis Sci. 1993 Apr;38(4):577-93. doi: 10.1007/BF01316785. Dig Dis Sci. 1993. PMID: 8462360 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Georg Thieme Verlag Stuttgart, New York